8 months ago
#GlomConHawaii 2025 π΄π session: Surrogate Endpoints and Biomarkers for Glomerular Diseases
Participants will discuss surrogate endpoints and biomarkers, emphasizing their role in trial design, patient stratification, and regulatory acceptance.